3 Location Data, E-Commerce Software and Healthcare Process Stocks With a Strong Future Roadmap: MapMyIndia, Unicommerce eSolutions and Sagility

Location data, e-commerce software and healthcare process stocks give investors exposure to software and services that help carmakers, online sellers and health insurers run operations. Client wins, recurring revenue and margins decide how much of that demand turns into profit.

This list covers three location data, e-commerce software and healthcare process stocks: MapMyIndia for digital maps and navigation technology, Unicommerce eSolutions for cloud software for e-commerce orders, inventory and shipping and Sagility for technology-enabled services for health insurers and providers. Every figure comes from the latest reported financials and the 12 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Location Data, E-Commerce Software and Healthcare Process Stocks?

Location data, e-commerce software and healthcare process stocks are shares of companies that sell maps, e-commerce software or healthcare process services. Results depend on client wins, recurring revenue and margins, so recurring revenue and margins separate the stronger names.

Location Data, E-Commerce Software and Healthcare Process Stocks at a Glance

The table compares size, valuation, return on equity and debt for the three location data, e-commerce software and healthcare process stocks as of the 12 Oct 2026 close.

Among technology stocks, all three trade at a premium to their industry P/E multiples.

Why Do Location Data, E-Commerce Software and Healthcare Process Stocks Have a Strong Roadmap in India?

Location data, e-commerce software and healthcare process stocks have a strong roadmap in India because connected vehicles, online selling and outsourced healthcare operations keep lifting demand for these technology firms. Three drivers stand out.

• Location data: Carmakers and businesses need map data.
• Online selling: Brands run orders and inventory on cloud software.
• Healthcare outsourcing: Insurers hand over claims and member services.

MapMyIndia: Digital Maps and Geospatial Software Anchor the Roadmap

MapMyIndia's roadmap rests on digital maps, geospatial software and navigation technology for carmakers, businesses and governments, with demand for location data supporting recurring revenue.

Revenue grew from Rs 241.99 crore in FY22 to Rs 526.50 crore in FY26, a 117.6% rise, and FY26 revenue was 2.1% higher than FY25. FY26 net profit was Rs 134.02 crore. In Q1 FY27, revenue grew 17.8% to Rs 159.37 crore, and net profit rose 8.6% to Rs 49.74 crore. Operating margin was 41.78% in FY26.

Debt to equity is 0.01 and return on equity is 14.83%. FY26 operating cash flow was Rs 93.33 crore against capital expenditure of Rs 42.40 crore. MapMyIndia paid a dividend of Rs 3.5 per share for FY26, a yield of 0.40%. At a P/E of 34.81 against an industry P/E of 17.30, the stock trades above its industry multiple.

What to watch: The P/E of 34.81 sits above the industry P/E of 17.30, so earnings delivery matters for the valuation.

Unicommerce eSolutions: E-Commerce Operations Software Drives the Pipeline

Unicommerce's roadmap rests on cloud software that runs order, inventory, warehouse and shipping operations for e-commerce brands and marketplaces, with more online sellers moving to a single operating system for their sales channels.

FY26 revenue was Rs 208.42 crore, 48.7% higher than FY25. FY26 net profit rose 16.1% to Rs 20.46 crore. In Q1 FY27, revenue grew 15.4% to Rs 52.79 crore, and net profit rose 20.3% to Rs 4.68 crore. Operating margin was 19.36% in FY26.

Debt to equity is 0.05 and return on equity is 10.60%. FY26 operating cash flow was Rs 47.00 crore against capital expenditure of Rs 2.13 crore. At a P/E of 42.28 against an industry P/E of 17.30, the stock trades above its industry multiple.

What to watch: The P/E of 42.28 sits above the industry P/E of 17.30, so earnings delivery matters for the valuation.

Sagility: Healthcare Services Contracts Build the Next Leg

Sagility's roadmap rests on technology-enabled business services for health insurers and healthcare providers, with long-term service contracts supporting revenue.

FY26 revenue was Rs 7,290.83 crore, 29.6% higher than FY25. FY26 net profit was Rs 924.77 crore. In Q1 FY27, revenue grew 27.7% to Rs 1,977.80 crore, and net profit rose 45.9% to Rs 216.81 crore. Operating margin was 25.38% in FY26.

Debt to equity is 0.12 and return on equity is 9.57%. FY26 operating cash flow was Rs 1,202.97 crore against capital expenditure of Rs 192.21 crore. Sagility paid a dividend of Rs 0.15 per share for FY26, a yield of 0.34%. At a P/E of 20.52 against an industry P/E of 17.30, the stock trades above its industry multiple.

What to watch: The P/E of 20.52 is a modest premium to the industry P/E of 17.30, so the next quarters' growth is the figure to follow.

Best Location Data, E-Commerce Software and Healthcare Process Stocks in India: MapMyIndia vs Unicommerce vs Sagility on Key Financials

Among the best location data, e-commerce software and healthcare process stocks in India, MapMyIndia leads on FY26 operating margin and return on equity; Unicommerce leads on FY26 revenue growth; Sagility leads on Q1 FY27 revenue growth and Q1 FY27 net profit growth. The table puts the numbers side by side.

Technology earnings follow client wins, recurring revenue and margins, so full-year numbers and quarterly trends together give a better view.

How to Evaluate Location Data, E-Commerce Software and Healthcare Process Stocks to Buy Before You Invest

A short checklist keeps the research consistent when you screen location data, e-commerce software and healthcare process stocks and shortlist location data, e-commerce software and healthcare process stocks to buy.

1. Compare each stock's P/E with its industry P/E, which is 17.30 for all three here.
2. Check revenue growth, operating margin and cash flow together.
3. Check whether revenue growth is turning into profit growth, not only sales.
4. Read operating cash flow against capital expenditure to see how growth is funded.
5. Watch debt to equity and interest cover before sizing a position.
6. Spread exposure across companies and business lines instead of one demand cycle.

Check the Univest Screener for live data on these location data, e-commerce software and healthcare process stocks

Risks to Consider Before Investing in Location Data, E-Commerce Software and Healthcare Process Stocks

• Valuation: Unicommerce and MapMyIndia trade at 42.28 and 34.81 times earnings against an industry multiple of 17.30.
• Client concentration: A few large clients can drive a big share of revenue.
• Contract renewals: Delays in renewals can affect quarterly results.
• Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.

Download the Univest iOS App or Univest Android App to track MapMyIndia, Unicommerce and Sagility live.

Final Take: Which Stock Has the Strongest Roadmap?

These three technology stocks cover digital maps, e-commerce operating software and healthcare process services. MapMyIndia leads on FY26 operating margin and return on equity; Unicommerce leads on FY26 revenue growth; Sagility leads on Q1 FY27 revenue growth and Q1 FY27 net profit growth.

Across location data, e-commerce software and healthcare process stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the location data, e-commerce software and healthcare process stocks to buy discussed here.

FAQs on Location Data, E-Commerce Software and Healthcare Process Stocks

Which are the best location data, e-commerce software and healthcare process stocks in India with a strong roadmap?

Ans. MapMyIndia, Unicommerce eSolutions and Sagility stand out for their roadmaps in digital maps, e-commerce operating software and healthcare process services. FY26 revenue growth was 2.1% at MapMyIndia, 48.7% at Unicommerce and 29.6% at Sagility, and return on equity ranges from 9.57% to 14.83%.

Is MapMyIndia a good stock to buy now?

Ans. MapMyIndia has a debt to equity ratio of 0.01, a return on equity of 14.83% and a P/E of 34.81 against an industry P/E of 17.30. Valuation, client flow and margins move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.

What is the P/E ratio of MapMyIndia, Unicommerce and Sagility?

Ans. The P/E ratio is 34.81 for MapMyIndia (industry 17.30), 42.28 for Unicommerce (industry 17.30) and 20.52 for Sagility (industry 17.30). All of them trade at or above the industry multiple.

Which of these location data, e-commerce software and healthcare process stocks has the highest return on equity?

Ans. MapMyIndia has the highest return on equity at 14.83%, followed by Unicommerce eSolutions at 10.60% and Sagility at 9.57%.

What are the risks of investing in location data, e-commerce software and healthcare process stocks?

Ans. The main risks are valuation, client concentration, contract renewals and quarterly trends. Unicommerce and MapMyIndia trade at 42.28 and 34.81 times earnings against an industry multiple of 17.30.

How did MapMyIndia, Unicommerce and Sagility perform in Q1 FY27?

Ans. MapMyIndia reported revenue of Rs 159.37 crore, up 17.8% year on year, and net profit rose 8.6% to Rs 49.74 crore. Unicommerce eSolutions reported revenue of Rs 52.79 crore, up 15.4% year on year, and net profit rose 20.3% to Rs 4.68 crore. Sagility reported revenue of Rs 1,977.80 crore, up 27.7% year on year, and net profit rose 45.9% to Rs 216.81 crore.

Do location data, e-commerce software and healthcare process stocks pay dividends?

Ans. MapMyIndia and Sagility pay dividends. The dividend yield is 0.40% for MapMyIndia and 0.34% for Sagility, based on dividends declared for FY26.

How can I invest in location data, e-commerce software and healthcare process stocks in India?

Ans. You can buy location data, e-commerce software and healthcare process stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.